The effects of glucose and lactate infusion on palmitate oxidation were compared with the effect of 2-tetradecylg]ycidic acid (TDGA), an irreversible inhibitor of the carnitine acyltransferase I, in nonmoxic canine myocardium. The initial capillary transit retention fraction of [l-"C]palmitate and its fractional distribution between oxidation and esterification in myocardium were measured by the residue detection method after intracoronary tracer injection, as well as by effluent measurements of "CO 2 , the end product of palmitate oxidation. TDGA reduced the initial capillary transit retention fraction (from 56±13% to 37±6%; jXO.001) and oxidation of palmitate (n=19), as also evidenced by the decrease in the fraction of tracer released as "CO 2 from 28±5% to 6±3% (p<0.001). Infusion of carbohydrate (glucose or lactate; n=6) reduced "CO 2 production from 30±7% to 7±4% (p<0.05) but did not alter the initial capillary transit retention fraction of tracer (59±5% vs. 56±10%; NS). The latter was due to increased esterification into neutral lipids (41 ±11% of injected palmitate after carbohydrate infusion versus 21 ±12% in control conditions), as measured from multiexponential curve fittings. When carbohydrates were given after inhibition of palmitate oxidation by TDGA (n =7), the "C tissue clearance kinetics were strikingly similar to those observed after carbohydrate infusion alone. Thus, enhanced metabolic trapping of [l-"C]palmitate in myocardium resulted in initial capillary transit retention fractions that were not different from control conditions (41 ±5% vs. 48±12%; NS) despite inhibition of oxidation. The results show that the intracellular metabolism of palmitate contributes to the control of its uptake by myocardium. The findings are consistent with inhibition of palmitate oxidation by carbohydrates occurring at the same site as TDGA. {Circulation Research 1989;65:1787-1797 " onesterified fatty acids (FA) are considered the major fuel substrate of the normoxic working heart. 2 ' 29 Although dependent on the arterial concentrations, mechanisms and regu-
lation of myocardial fatty acid uptake remain controversial. 10 The extent to which the oxidation rate of fatty acid modulates their myocardialmptake remains uncertain. In cytosol, nonesterified fatty acids are activated to acyl-coenzyme A (CoA) units, which then are directly esterified further to neutral lipids or transported into the mitochondria for oxidation. The partition between esterification and oxidation is regulated by several factors as for example the activity of glycerophosphate acyltransferase, which catalyzes the initial step in the synthesis of triacylglycerol, and of the carnitine acyltransferases, which act as carriers of the long chain FA CoA to the intramitochondrial oxidation site. 3 In liver, glycerophosphate was shown to inhibit tissue oxidation by shifting FA CoA toward esterification; the existence of this mechanism remains undetermined in myocardium. Findings by McGarry et al 5 -17 suggest that malonyl-CoA (derived from carboxylation of acetyl-CoA) regulates the activity of carnitine acyltransferase I. Intracellular concentrations of malonyl-CoA vary with plasma substrate levels as a function of the dietary state. 17 As the heart can resort to alternate substrates in response to changes in substrate levels and oxidation of FA shifts to carbohydrates, the carnitine acyltransferase possibly plays a key role in regulating both selection and partition of FA CoA between oxidation and esterification.
With specific inhibitors of FA metabolism, changes in myocardial extraction and turnover of metabolites in response to a denned metabolic block can be evaluated. Most of the information on substrate metabolism and its response to inhibition of specific metabolic steps has been generated in ex vivo heart preparations. 1 -17 - 22 As tracers of metabolism labeled with positron emitting isotopes and positron emission tomography have become available, regional myocardial metabolism can now be studied in vivo. Specifically, the tissue kinetics of [l-n C]palmitatc can be used as a probe of FA metabolism. 24 The purpose of the present study was therefore to test this new approach against existing knowledge of FA metabolism in normal myocardium as well as to examine the effects of specific inhibitors, either physiological or chemical, on the myocardial tissue kinetics of [l-"C]palmitate. In open chest dogs with intracoronary tracer injection, we employed the residue detection method as well as effluent measurements of "C activity and n CO 2 as the end product of [l-^Clpalmitate oxidation. Studies were performed at control and again after extramitochondrial inhibition of FA oxidation by 2tetradecylglycidic acid (TDGA). This drug acts as a selective and irreversible inhibitor of the carnitine acyltransferase 1.13,22,28 Findings were then compared with responses to naturally occurring inhibitors of FA oxidation by intravenous infusion of the alternate substrates glucose and lactate. In a third group of experiments, additional effects of carbohydrate administration after inhibition of FA oxidation by TDGA were studied.
Materials and Methods

Animal Preparation
Twenty-five dogs weighing 19-30 kg (mean, 24.5) were anesthetized with intravenous pentobarbital (25 mg/kg) after a 16-36-hour fast, intubated, and ventilated with a 50% mixture of oxygen and room air. Catheters were advanced into the aorta (7F) and into the left ventricle through the apex (18 gauge) for withdrawal of arterial blood. Aortic and left ventricular pressures were monitored with either a fluid filled catheter connected to a pressure transducer (Statham P23 Db, Gould Instruments, Cleveland, Ohioy Or a tip micfomanometer (Millar Instruments, Houston, Texas) attached to an 8F pigtail catheter inserted through the left carotid artery.
After a left thoracotomy, the heart was suspended in a pericardial cradle. A polyvinyl cannula was advanced into the left atrium through its appendage for administration of radiolabeled microspheres (15 /im, Du Pont, North Billerica, Massachusetts). A 25 -gauge needle connected to plastic tubing (dead space, 0.2 ml) was inserted into the proximal left anterior descending coronary artery or, when not possible, into the left circumflex coronary artery (n=3) for intracoronary injection of [l-u C]palmitate. In 11 dogs with tracer injections into the left anterior descending coronary artery, rapid simultaneous arteriovenous sampling across the heart for effluent activity determination was performed. Arterial blood was withdrawn directly from the left ventricle and coronary venous effluent from the anterior interventricularvein, draining the territory of the left anterior descending coronary artery. In 18 dogs, a pair of ultrasonic crystals was implanted in the anterior wall for measurements of systolic wall thickening. One crystal was inserted tangentialry through the wall to the subendocardium, and the other one was sewn to the epicardium so that it directly faced the subendocardial crystal. Both crystals were connected to a sonomicrometer (Triton Technical, San Diego, California). The position of the subendocardial crystal within the inner third of the ventricular wall was verified post mortem, and data from improperly positioned gauges were disregarded (n-3). However, measurements obtained from gauges implanted in the anterior papillary muscle were included.
Experimental Protocol
After instrumentation and a 20-minute recovery period, a tracer amount of [l-u C]palmitate, contained in 0.1-0.4 ml of normal saline with 6% albumin, was flushed as a bolus directly into the coronary artery. The specific activity of the [l-"C]palmitate was greater than 7 Ci/mmol, and the maximum injected dose of [l-"C]palmitatc was less than 35 nmol. Myocardial n C tissue activity and its changes over time were recorded with a 100msec temporal resolution for 40 minutes by a collimated 7.5 by 5.0 cm Nal (Tl) scintillation probe positioned over the heart and interfaced with a computer (Scintigraphic Data Analyzer 5407, Hewlett-Packard, Palo Alto, California). Recorded counts were corrected for physical decay of n C activity (half-life, 20.4 minutes) with time 0 at time of peak activity. This approach, which has been extensively validated in our laboratory, 23 -25 minimizes tracer recirculation and contamination of the primary tissue time activity curve. Depending on the study protocol, intracoronary injections of [l-^Clpalmitate were repeated in the same animal up to four times, resulting in a total of 88 experimental runs. The preparation has been demonstrated preyiousjy to be metabolically stable for several hours, as indicated by multiple measurement of [l-n C]palmitate kinetics. 26 Sequential increases in tracer bolus activity concentrations with each injection from a minimum of 75 fid to a maximum of 250 /xCi, and a 60-90-minute time interval (i.e., 3-4.5 half-lives of U C) between tracer injections minimized possible contamination of recorded time activity curves by residual activity from the preceding injection. This contribution was within the limits of statistical variations in count rates and typically ranged from 1% to 4%.
The following study protocols were performed:
In study protocol I, 19 dogs were studied at control and again 50 minutes later after a slow (10 minutes) intravenous infusion of 10 mg/kg TDGA (McNeil Pharmaceutical, Spring House, Pennsylvania), an irreversible inhibitor of the carnitine palmitoyltransferase I (CPT I). TDGA was dissolved in 2.4-2.9 ml absolute ethanol. To exclude any possible effects of solvent on tracer tissue kinetics, five additional studies were performed after infusion of the same amount of solvent only over the same time period.
In study protocol II, the effect of TDGA on [l-n C]palmitate tissue kinetics was compared in six dogs with that of glucose and lactate as physiological inhibitors of FA oxidation in myocardium. Therefore, studies were performed at control and again during intravenous carbohydrate infusion. Sodium L-lactate (5 M, pH 7) was infused in four dogs (2 ml bolus followed by constant infusion at a rate of 0.8-1.0 miymin) and D-glucose (0.6 M, 2.0-2.5 ml/min) with 200 units of insulin (regular Iletin; Eli Lilly and Company, Indianapolis, Indiana) in two additional dogs.
In study protocol III, the combined effects of physiological and chemical inhibition were explored. Carbohydrate was infused intravenously after FA oxidation had been inhibited with TDGA. These studies were performed at the end of protocol I in a subgroup of 11 dogs. Lactate was given in two dogs and glucose in five at the rate and concentrations described earlier. Four dogs randomly received saline (100-150 ml) instead of carbohydrates to ascertain the constancy of TDGA inhibition and served as controls.
AllTHeasTrrements in these intervention-studies were performed only after a 20-minute steady-state infusion period. During each experimental run, simultaneous arteriovenous sampling across the myocardium under study was performed. Microsphere blood flow measurements and plasma levels of glucose, lactate, FA, hemoglobin concentration, hematocrit and oxygen content were obtained immediately before each injection of [l-n C]palmitate. Arterial ethanol concentrations were determined in 10 dogs.
At the end of each experiment, the myocardial territory downstream of the intracoronary tracer injection site was delineated by in vivo intracoronary injection of 1 ml gentian violet (Bane Drug Co, Baltimore, MD). The animals were then killed by an overdose of pentobarbital followed by concentrated potassium chloride injection. Tissue samples from four to five left ventricular myocardial cross sections were divided into endocardial and epicardial halves and their weight determined in disposable preweighed tubes. Tissue activity concentrations of various microspheres ("Co, 113 Sn, and 103 Ru) were measured by well counting (multichannel analyzer, Tracer Instruments, Austin, Texas). The average transmural blood flow in blue stained myocardium was used for calculation of regional myocardial substrate utilization employing the Fick principle. 8 Blood gases were analyzed with a 168 pH blood gas analyzer (Corning Glass Works, Corning, New York). Glucose, lactate, and FA concentrations were determined enzymatically as described earlier. 11.12,21 Steady-state extraction fractions E (%) for unlabeled substrates were calculated as:
arterial-coronary venous concentrations arterial concentrations
The following oxygen equivalents were used: 1 mmol glucose = 134.5 ml O 2 , and 1 mmol lactate = 66.2 ml O 2 .1 3 These calculations are based on the assumption that both substrates undergo complete oxidation in normoxic myocardium. This approximation cannot be applied to FA, in particular after inhibition of their oxidation.
Analysis of Myocardial Tissue Time Activity Curves
The decay-corrected tissue time activity curves were analyzed with multiple exponential leastsquare fitting routines. The high frequency events early after tracer injection were then analyzed from a high time resolution curve during the first 180 seconds (0.5 second sampling per curve point; see Figure 1 ). Clearance of nonretained [l-n C]palmitate from the vascular and interstitial spaces is completed within the first minute. Therefore, the fraction of tracer retained after that time in myocardium following a single pass through the coronary circulation, defined as first capillary transit retention fraction, isdetermined by extrapolating the slope of the slower phase on the high time resolution clifve (i.e., after 1 minute) back to the time of peak activity. As the volume of the intracoronary activity bolus is far smaller than the volume of the coronary circulation, there is an approximately 1-2-second time period during which the probe sees all activity delivered into the coronary circulation. Therefore, the peak activity is proportional to the total dose injected and the ratio of retained over peak activity represents the initial capillary transit retention fraction. The subsequent clearance of initially retained [l-n C]palmitate from myocardium was analyzed over 40 minutes from a lower temporal resolution curve on which each curve point represents an average activity for 15 seconds (Figure 1) . The low temporal resolution tissue time activity curve characteristically reveals two components, an early rapid and a late slow phase. Both components were analyzed by multiexponential least square fitting routines, and their relative sizes and clearance half-times were determined. The relative sizes of both the early rapid and the late slow clearance phase are expressed as percent of peak activity or total n C activity administered. Clearance half-times of each curve component are expressed in minutes.
Effluent Measurements of Oxidized and Nonmetabolized Tracer
To quantitate the efflux of oxidized and nonmetabolized tracer from myocardium relative to the tissue time activity curves, multiple arteriovenous samples (22 ±3) were obtained manually in 11 dogs during the first 20 minutes after [1-C]palmitate injection, sampling commencing 1 minute after injection. The contribution of U CO 2 and non-CO 2 "C to the total radioactivity in the effluent "C activity was measured as previously described. 23 ' 24 The 2.0-ml samples were divided into two 1.0-ml aliquots: one was added to 3 ml of 0.05N NaOH and the other to 3 ml of 2N HC1. Then, 0.5 ml Na bicarbonate (0.9 M) was added to the acidified samples which were vortexed and placed for 5 minutes in a heated (70° C) ultrasonic bath. From the weight of the samples and their decay-corrected "C activity measured by well counting, release of "CO 2 and non-CO 2 "C activity from myocardium was calculated as follows. Because no CO 2 is released from the alkaline-treated samples, the difference in activity between the alkaline-and the acid-treated samples represents the n CO 2 -concentrations in whole blood. The residual "C activity in the acidified blood samples (after evaporation of "CO 2 ) was shown previously to represent mainly unaltered [l-"C]palmitate that diffuses back from myocardium. 7 -24 The amount of CO 2 and [1-"C] palmitate released over the 1 to 20 minute postinjection interval was calculated by integrating the arteriovenous activity concentration differences over that time period and normalized to the change in total tissue activity over the same time period as measured externally with the scintillation detector probe. These integrated activity values were then expressed as a fraction of peak activity on the tissue time activity curve, yielding a number without dimension.
Statistical Analysis
Values are expressed as mean±SD. The t test for paired samples or one-way analysis of variance with adjustment of probability values by the Bonferroni method were used whenever appropriate. A value of p<,0.05 was considered as statistically significant.
Results
Effects of Camitine Acyltransferase I Inhibition by 2-Tetradecylgfycidic Acid (Study Protocol I): Tracer Tissue Kinetics (Residue Detection) and Effluent Measurements
The first capillary transit retention fraction of [l-n C]palmitate decreased significantly from 56± 13% at control to 37±6% after TDGA (/>< 0.001; Table  1 ). As shown on the high temporal resolution curve in Figure 2 , TDGA increased the initial vascular and interstitial curve components, suggesting that after crossing the vascular and sarcolemmal membranes, a smaller fraction of [l-n C]palmitate was tfapped effectively in myocardium and more was diffused back into the vascular space. Figure 3 illustrates the tissue clearance curve acquired for 40 minutes. At control, the curves are characterized by the two clearance curve components reflecting the fate of metabolically trapped {l-u C]palmitate. According Relative size (EPS in percent) and half-time (ET 1/2 in minutes) of the carry phase and relative size (LPS in percent) and half-time (LT 1/2 in minutes) of the late phase of the tissue "C activity clearance curve. TDGA, 2-tetradecylgrycidic acid; RF, retention fraction (%); NS, statistically not significant. Efflux data are in percent of peak activity (n =6). Substrate levels are expressed in /xmol/100 ml plasma, myocardial oxygen consumption is given in ml/min/10 g, and the substrate consumptions are in pimol/min/100 g. Mean values are given with standard deviations.
to previous studies from this laboratory 24 -26 and others, 15 the early rapid phase is thought to represent the fraction of [l-H C]palmitate that has entered oxidation and its rate, whereas the late slow phase reflects the fraction of tracer that has been esterified and its rate of turnover. After TDGA, the time activity curve was approximated best by three exponential fits as the clearance curve revealed an additional very early and rapid vascular and interstitial phase. TDGA did not significantly alter the relative size and half-time of the late slow clearance curve component, while it reduced the size of the early rapid phase markedly from 49% at control to 15% after TDGA in this representative example. Note also the shorter half-time of the early phase, which fell from 4.4 minutes at control to 2.2 minutes after TDGA. Table 1 summarizes the data for the entire group of 19 dogs. TDGA did not affect the relative size and half-time of the late curve component while it significantly reduced the relative size of the early rapid phase from 43±15% to 15±6% (p<0.O01). The clearance half-time of the early phase similarly decreased from 4.4±1.4 to 2.8±1.3 minutes (p<0.001). The decrease in the size of the early rapid turnover phase suggests a decline in FA oxidation. Consistent with a decline in oxidation of [l-H C]palmitate was a marked decrease in "CO 2 release as determined independently from the coronary venous effluent measurements. At control, 28±5% of peak activity was released in form of U CO 2 which decreased to only 6±3% after TDGA (p<0.001). Figure 4 describes the relation between the effluent measurements and the initial 20 minutes of the tissue time activity curve. In control experiments, the effluent activity was dominated by n CO 2 and release of activity unrelated to n CO 2 , most likely nonmetabolized tracer, was largely limited to the first 2 minutes after injection. TDGA inhibition however caused a marked reduction in "CO 2 release such that non-CO 2 related U C activity contributed equally to the effluent function. This finding accounts for the paradoxical shortening of the half-time of the early clearance phase after TDGA, which probably reflected mostly back diffusion of nonmetabolized [l-n C]palmitate.
Hemodynamics, Blood Flow, and Substrate Utilization
TDGA caused a small but significant deterioration in global and regional systolic left ventricular function ( Figure 5 ): the left ventricular peak systolic pressure decreased from 123±17 to 113±15 mm Hg (/?<0.01), the mean aortic pressure from lll±20 to 100±14 mm Hg (p<0.005), the peak positive dP/dt from 96±L33%rto 89±19%K)f control (/?<O,Q5). The heart rate (140±21 vs. 141+21 beats/min), the left ventricular end-diastolic pressure (8.7±3.8 vs. 9.2±4.9 mm Hg), and the peak negative dP/dt (98± 11% vs. 93±7% of control) were unchanged. While end-diastolic wall thickness remained constant (12.4±3.1 vs. 12.4±3.1 mm), the percent systolic wall thickening declined from 22.2±10.0% to 17.8±8.9% (/?<0.001). In contrast, myocardial blood flow increased by 20% from 101±7 to 122±48 ml/min/100 g (p<0.025), although the ratio of endocardia! over epicardial blood flow remained constant (1.13±0.16 at control vs. 1.12±0.18 after TDGA). As myocardial oxygen consumption was slightly reduced (from 11.4±3.6 to 10.6+3.7 ml/ min/100 g; p<0.0l), these findings possibly imply reduced mechanical efficiency. Although there were no significant changes in the calculated myocardial consumption of glucose, lactate, and FA, the steady-state extraction of FA decreased markedly from 67±31% to 19±23% (/?<0.001). This change most likely was due to a rise in arterial FA concentrations caused by peripheral effects of TDGA. Assuming complete oxidation of glucose and lactate, calculated oxygen equivalents for both carbohydrates accounted for 45 ±25% of myocardial oxygen consumption at control and for 61 ±26% after TDGA (NS).
Effect of the Solvent
At the dosage used (2.4-2.9 ml), ethanol alone did not affect the tissue [l-"C]palmitate clearance kinetics. Retention fractions (53±10% vs. 54±9%), the relative size of the early (46±17% vs. 47±7%) and late (17±5% vs. 17±7%) phase were unchanged. Furthermore, infusion of ethanol alone had no effect on hemodynamic parameters. Ethanol levels averaged 0.5±0.8 mg/ml in this subgroup of five dogs as compared with 0.6±l.l mg/ml in 10 dogs in which ethanol levels were measured after TDGA administration. These findings indicate that ethanol at the dosage used as the solvent for TDGA exerted no effect on transmembranous transport and subsequent metabolism of [l-n C]palmitate.
Effects of Glucose-Insulin and Lactate Infusion (Study Protocol II)
The effect of lactate infusion on [l-"C]palmitate tissue kinetics is illustrated by an example in Figure  6 . Lactate reduced the size of the early rapid clearance phase from 46% to 12% and increased the size of the late phase from 22% to 50%.
Intravenously infused glucose-insulin or lactate affected the tissue kinetics of [l-n C]palmitate in a similar and reproducible manner: a marked decline in the size of the early phase (from 46±15% to 13 ±6%) was offset by an increase in the size of the late phase (from 21±12% to 41±11%) resulting in no significant change in retention fraction (from 59±5% to 54±10%) as summarized for all studies in Table 2 . Note also that the clearance half-time of the early phase tended to decrease (from 3.9±1.0 to 2.6±0.4 minutes).
The decline in the size of the early phase of the tissue time activity curves reflected reduced oxidation of [l-n C]palmitate as confirmed by the decrease in n CO 2 production from 30±7% to 7±4% of total dose. Glucose-insulin infusion caused a threefold increase in arterial glucose levels and lactate infusion a 10-fold increase in arterial lactate levels. Both interventions caused a marked reduction in arterial FA levels, which were undetectable in two dogs. Interestingly, in both dogs, glucose-insulin infusion doubled arterial lactate levels. Thus, when both glucose-insulin and lactate were infused, lactate became the primary substrate for myocardium as its utilization increased threefold to fourfold. The shift in substrate utilization from FA to lactate was not accompanied by significant changes in myocardial blood flow (120±29 vs. 126±23 ml/min/100 g; NS), heart rate (148+28 vs. 138+43 beats/min; NS), or left ventricular peak systolic (124+15 vs. 127±6 mm Hg; NS) or end-diastolic pressure (8.6±4.2 vs. 8.6±29 mm Hg; NS).
Effects of Glucose-Insulin and Lactate Infusion During Inhibition of Fatty Acid Oxidation by 2-Tetradecylgfycidic Acid (Study Protocol III)
As illustrated in Figure 7 , infusion of either glucose-insulin or lactate during inhibition of FA oxidation by TDGA markedly affected the tissue clearance curves. The size of the late phase increased after glucose-insulin infusion from 18% to 34% in the example in Figure 6 . In contrast, the relative size of the early phase decreased even further, suggesting that the major part of [l-n C]palmitate retained in myocardium was stored in the endogenous lipid pools. Again, there was no significant difference between the effects of glucose-insulin and of lactate infusion. Moreover, the ll C tissue clearance kinetics were strikingly similar to those observed after carbohydrate infusion alone (see study protocol II). The data are summarized in Table 3 which lists the effects of both glucose- insulin and lactate infusion on [l-n C]palmitate clearance curves during CPT I inhibition by TDGA.
When saline only was infused in control dogs, the effect of TDGA on the [l-11 C]palmitate tissue clearance kinetics remained stable throughout the study period. This observation is consistent with irreversible TDGA induced inhibition of CPT I, at least for the time of the study. Enhanced metabolic trapping of [l-"C]palmitate in myocardium after carbohydrate infusion resulted in higher first pass capillary transit retention fractions, which no longer differed from control and averaged 41 ±5% as compared with 48±12% (NS) at control. Comparison of the two groups of dogs (saline and carbohydrates) revealed some differences in the [l-"C]palmitate tissue kinetics at control conditions. Although not statistically significant, the control data suggest a smaller contribution of FA oxidation to overall substrate metabolism in the dogs to be infused with carbohydrates. This might be ascribed to substrate competition because baseline lactate levels were significantly higher in dogs subsequently infused with carbohydrates as compared with those that subsequently received only saline. Nevertheless, in response to carbohydrate infusion, arterial substrate levels changed and consumption of glucose, and even more so of lactate, rose. The sum of oxygen equivalents for both carbohydrates accounted for 120 ±54% of the measured myocardial oxygen consumption as opposed to 51 ±30% at control and 50 ±32% after TDGA. No significant changes in substrate levels and consumption were observed in the dogs infused with saline. After TDGA, myocardial blood flow tended to increase from 107±37 to 154±81 ml/min/100 g in dogs allocated to saline infusion and from 88±25 to 111±142 ml/min/100 g in dogs to be infused with glucoseinsulin or lactate, but these changes failed to reach statistically significant levels. Blood flow remained subsequently constant in the two groups of dogs.
Discussion
Fatty acids cross the plasma membrane and are activated^ at the outer mitochondrial membrane by esterification with CoA to form acyl-CoA. Fatty acyl-CoA can then be esterified with glycefel in the cytosol to form triglycerides or transported into the mitochondrion via a carnitine-dependent mechanism for oxidation. The fate of the fatty acyl-CoA is thus a function of the relative rates of these competing pathways. Triglycerides stored in myocardium can be broken down to release fatty acids when the myocardium needs endogenous fuel, the cyclical pathway of synthesis and degradation of triglyceride constituting the fatty acid-triglyceride cycle.
Our findings further support the value of [l-"C]pa]mitate as a tracer of FA metabolism. The present analytic approach to the tissue time activity curves provides semi quantitative information on retention and metabolic fate of fatty acid extracted by myocardium. Our major findings can be summarized as follows: 1) uptake of FA by heart muscle does not solely depend on their availability in plasma since intracellular metabolism of FA contributes to the control of their retention; 2) carbohydrates and, in particular, lactate compete with FA for oxidation in normoxic canine myocardium; and 3) the results are consistent with inhibition of FA oxidation by carbohydrates occurring at the same site as TDGA.
Comparison With Previous Data
Increasing evidence by McGarry and others 5 -14 -17 suggests that formation of long chain acylcamitine units by the camitine acyltransferase I is regulated by intracellular levels of malonyl-CoA that fluctuate in response to changes in the physiological state and in pH. Recent observations have reported the presence of malonyl-CoA in myocardium at intracellular concentrations that would interact with the regulatory site of the enzyme CPT I and modulate its activity. 17 We found that TDGA, which inhibits CPT I by irreversible binding probably at its regulatory site, 5 markedly decreased oxidation of [1-C] palmitate. Despite a significant increase in free fatty acid plasma concentrations secondary to peripheral effects of TDGA, the first capillary transit retention fraction fell. Interestingly, carbohydrate infusion during CPT I inhibition by TDGA raised the retention fraction of [l-n C]palmitate toward control values despite a decrease in arterial FA levels. This phenomenon is likely to be related to an increased intracellular availability of glycerophosphate because the larger fraction of [1-C]palmitate that was retained in myocardium entered the slow turnover or endogenous lipid pool. It also suggests that TDGA at the dose given did not inhibit activation of long-chain FA to acyl-CoA units nor their subsequent esterification to neutral lipids. Thus, [l-n C]palmitate tissue kinetics during carbohydrate infusion were virtually indistinguishable in the presence or absence of CPT I inhibition by TDGA, suggesting that the "physiological" inhibition of [l-u C]palmitate oxidation due to carbohydrates does not occur at a site other than CPT I. Similar observations were reported by Bielefeld et al 1 comparing the effect of lactate and oxfenicine, another inhibitor of CPT I activity. Both studies are in agreement with the findings reported by others 6 that octanoate oxidation, which does not require the carnitine system for entry into mitochondria, is not inhibited by pyruvate or lactate or lactate plus glucose. Additional and more direct evidence could be obtained by measuring malonyl-CoA levels in biopsy samples during these various interventions.
The issue remains why inhibition of FA oxidation by TDGA resulted in a small but consistent deterioration in left ventricular systolic performance, given a 20% increase in myocardial blood flow. 9 In addition to a direct negative inotropic effect of TDGA, which seems unlikely, 19 one might speculate on several mechanisms including reduced availability or reduced utilization of alternate substrates, accumulation of inhibitory metabolites or a combination of any of these factors. The drug has a strong hypoglycemic effect, 28 although within the time frame of the present study no significant fall in arterial glucose and lactate levels occurred. These findings argue against substrate shortage as a possible mechanism. Surprisingly, the calculated consumption of carbohydrates did not significantly increase after inhibition of FA oxidation by TDGA. Thus, utilization of alternate substrates might indeed be reduced as observed by others in rat hearts after inhibition of FA oxidation by D-4hydroxyphenylglycine, which also acts at the CPT I level." These authors observed inhibition of glycolysis at the glyceraldehyde-3-phosphate dehydrogenase level due to a change in the redox state of the cell and a reduced availability of pyruvate for reduced nicotinamide adenine dinucleotide oxidation. Another possible mechanism implies a TDGA induced increase in cytosolic levels of acyl-CoA intermediates as observed in hepatocytes. 28 Accumulation of these metabolites is known to inhibit adenine nucleotide translocase, the critical carrier system for ATP transport between the mitochondrial matrix and the cytosol reversibly. 16 -27 Both hypotheses are compatible with the observation that increasing glucose and/or lactate levels, as performed under protocol III, restored left ventricular performance to normal. The involved mechanism would be either an increase in glycolytic flux by a mass effect or a removal of toxic acyl-CoA intermediates through esterification. 20 
Implications for Studies With Positron Emission Tomography
Previous work has provided indirect evidence supporting the relative size and clearance half-time of the early rapid phase as indexes of FA oxidation. For instance, Schelbert et a] 23 ' 24 have described the relation between cardiac work, [l-"C]palmitate tis-sue kinetics and amounts and rates of n CO 2 release. Thus, the fractional distribution of [l-n C]palmitate and the slope of the early rapid phase increased in proportion with myocardial oxygen consumption. This is in keeping with the hypothesis that at a higher workload more [l-u C]palmitate enters oxidative pathways and is oxidized more rapidly. An alternate approach for characterizing the relation of the externally observed myocardial tissue "C activity clearance to myocardial FA metabolism is the inhibition of specific metabolic steps by drugs or physiologically as advocated by McMillin-Wood. 18 As anticipated, inhibition of acylcarnitine transfer from cytosol to the mitochondrial matrix by TDGA or, physiologically by glucose or lactate, caused a reduction in [l-n C]palmitate oxidation as evidenced by the marked decline in the size of the early rapid clearance curve component of the myocardial tissue U C clearance curve as well as by significantly less H CO 2 release. Furthermore, carbohydrate administration induced greater trapping of U C activity in the slow turnover endogenous lipid pool.
Tissue clearance rates should however be used with caution as indices of oxidation of [1-"C] palmitate. The half-time of the early rapid phase actually shortened despite reduced oxidation of [l-n C]palmitate. Besides the rate of [l-n C]palmitate oxidation and the rate of n CO 2 removal from myocardium, back diffusion of nonmetabolized [l-n C]palmitate and the volume of distribution of the tracer also determine the slope of the curve component. We can only speculate on possible changes in the distribution volume of various radiolabeled FA intermediates, since we did not perform serial subcellular tissue assays. However, the shortening of the half-time of the early rapid clearance phase after TDGA could be ascribed to increased back diffusion of [l-n C]palmitate that dominated this curve component and therefore rose from 4.9±1.6% at control to 7.5±4.5% of the total dose. Similar findings were reported by Fox et al 7 during hypoxia and ischemia. After glucose and/or lactate infusion, neither [l-"C]palmitate efflux nor the halftime of the early rapid phase changed significantly, consistent with the preserved retention fraction of the tracer under these conditions. Thus, the relation between metabolic trapping and tracer back diffusion appears to vary under different circumstances and has to be elucidated within each study condition before tissue clearance rates derived from studies with positron emission tomography can be interpreted unambiguously.
